ENDO INVESTORS
Endo makes investments in game-changing early stage companies improving outcomes for large patient populations affected by various chronic diseases. Endo is backed by a group of mission-oriented investors and was created in response to a deficit of early-stage capital focused on companies impacting diabetes and other major global health issues.
ENDO INVESTORS
Social Links:
Founded:
2013-01-01
Status:
Active
Technology used in webpage:
Microsoft Exchange Online
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-08-13 | Cecelia Health | Endo Investors investment in Series B - Cecelia Health | 13 M USD |
More informations about "Endo Investors"
Endo Investors – Investing in Life Sciences
Endo makes investments in game-changing early-stage companies improving outcomes for large patient populations affected by various chronic diseases. Endo is backed by a group of mission-oriented investors and was created in …See details»
Endo Reports First-Quarter 2025 Financial Results and Reaffirms …
Mar 31, 2025 XIAFLEX ® revenues grew 7% compared to first-quarter 2024; The Company reaffirms 2025 revenue guidance of $1,775 to $1,860 million and adjusted EBITDA guidance …See details»
Endo Investor Relations - SEC Filings
1 day ago Investors > Financial Information. 2008861 1593034. Year Trailing 12-Months Calendar Year 2025 Calendar Year 2024. ... 1-800-462-ENDO (3636) Contact Us; Stay in …See details»
Press - Endo Investors
Cecelia Health closes $13 million Series B, Rittenhouse’s Saul Richter and Endo Investors’ Eric Edidin to join board of directors, number of members now exceeds 150,000. Read the full …See details»
Endo Investors investment portfolio - PitchBook
Endo Investors's latest investment was on 17-Oct-2022 in Biolinq, a company within the Monitoring Equipment industry. Data Transparency. Meet our data hygiene team. Discover how our experts ensure you’re getting the most …See details»
Meet the Team – Endo Investors
Home; About Us; Portfolio Companies; Press; Contact; Meet the TeamSee details»
Investors | Endo - Press Releases
Mar 24, 2025 XIAFLEX® revenues grew 7% compared to first-quarter 2024 The Company reaffirms 2025 revenue guidance of $1,775 to $1,860 million and adjusted EBITDA guidance …See details»
Endo International 2025 Company Profile: Valuation, Investors ...
Endo International General Information Description. Manufacturer of specialty pharmaceuticals designed to meet unique medical needs. The company offers a broad range of life-enhancing …See details»
Endo Investors - Crunchbase Investor Profile
Endo makes investments in game-changing early stage companies improving outcomes for large patient populations affected by various chronic diseases. Endo is backed by a group of mission-oriented investors and was created in …See details»
Endo Announces Divestiture of International Pharmaceuticals
MALVERN, Pa., March 11, 2025 /CNW/ -- Endo, Inc. ("Endo" or the "Company") (OTCQX: NDOI) today announced it has entered into a definitive agreement to divest its International …See details»
Media | Endo - Endo International
Mar 11, 2025 Endo to Report First Quarter 2025 Financial Results on May 7, 2025. March 26, 2025. Endo Launches Spatial Computing Simulator to Create a Fully Immersive Learning …See details»
Endo Inc Stock Price Today | OTC NDOI - Investing.com Canada
1 day ago Endo Inc stock price live, this page displays OTC NDOI stock exchange data. View the NDOI premarket stock price ahead of the market session or assess the after hours quote. …See details»
Endo Inc. Moves Forward with Strategic Business Repositioning
Mar 11, 2025 Endo, Inc. (OTCQX: NDOI) has embarked on a significant transformation journey by announcing its decision to divest its International Pharmaceuticals business. This …See details»
Endo Investors - Investments, Portfolio & Company Exits
Aug 13, 2020 Endo Investors 's most notable exits include Bigfoot Biomedical and Capillary Biomedical. Which industries has this organization had the most exits in? Show . Bigfoot …See details»
Investors | Endo - Board Committees
Oversees Endo’s legal and fiduciary obligations with respect to matters involving the accounting, auditing, financial reporting, internal control, internal audit, and regulatory compliance …See details»
Board of Directors | Endo
Paul Efron is a private investor and former Executive Chairman of Oodles Energy, Inc., which installs and operates fast DC chargers in apartments and hotels. He served in that role since …See details»
NDOI Stock Price | Endo Inc. Stock Quote (U.S.: OTC) - MarketWatch
May 5, 2025 NDOI | Complete Endo Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.See details»
Mallinckrodt and Endo to Combine to Create a Global, Scaled ...
Mar 13, 2025 Endo Contacts. Investor Relations Juan Avendano [email protected] . Media Linda Huss [email protected] . 1 Pro forma net debt / 2025E pro forma …See details»
Endo Announces Divestiture of International Pharmaceuticals …
MALVERN, Pa., March 11, 2025 /PRNewswire/ -- Endo, Inc. ("Endo" or the "Company") (OTCQX: NDOI) today announced it has entered into a definitive agreement to divest its International …See details»
Mallinckrodt and Endo Announce Significant Progress in Proposed …
7 hours ago Endo Contacts. Investor Relations Juan Avendano [email protected] Media Linda Huss [email protected] SOURCE Mallinckrodt plc. WANT YOUR COMPANY'S NEWS …See details»